CONTACT US   |  (864) 397-5101

Nephron names Morgan Nichols Scarnecchia as Chief of Staff

Morgan Scarnecchia

Courtesy of Midlands Biz

Nephron Pharmaceuticals Corporation welcomed Morgan Nichols Scarnecchia as its Chief of Staff. In her new role, Scarnecchia will implement strategic business initiatives, manage daily operations and work alongside CEO, Lou Kennedy, in internal and external affairs.

“As two women who grew up in Lexington, Morgan and I not only share a great passion for the life sciences, but also South Carolina and the Midlands,” said Nephron CEO and Owner Lou Kennedy. “She is a great addition to our strong female leadership here at Nephron – and by working together, we will continue to drive Nephron forward.”

Before joining the Nephron team, Scarnecchia was the Director of Corporate Affairs for KOR Medical, where she built and managed the start-up’s key corporate accounts and communications for its various entities. Prior to that, she served first as an intern and later as Investor Relations Manager for SCbio.

Scarnecchia has served as Corporate Affairs and Investor Relations Manager at SCbio, where she was responsible for board and investor communications and leading life sciences workforce initiatives like the association’s K-12 education programs. She began her career at the biotechnology organization as its Membership and Marketing Coordinator, recruiting life science companies and implementing new stakeholder engagement strategies.

In 2019, Scarnecchia was crowned Miss South Carolina. During her reign, she traveled across South Carolina promoting Stronger With STEM, a personal initiative created to promote a 21st-century workforce in the areas of science, technology, engineering and mathematics.

Scarnecchia received a Bachelor of Science in Genetics from Clemson University and is currently pursuing her Master of Biotechnology and Business from Johns Hopkins University.

A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. For more information, please visit

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.